1219 results
-
List item
Committee for Medicinal Products for Human Use (CHMP): 14-17 October 2024
European Medicines Agency, Amsterdam, the Netherlands, from 14/10/2024 to 17/10/2024, Last updated: 29/11/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 23-26 January 2023
European Medicines Agency, Amsterdam, the Netherlands, from 23/01/2023 to 26/01/2023, Last updated: 29/11/2022 -
List item
European Medicines Agency - Parenteral Drug Association (PDA) bilateral meeting
European Medicines Agency, Amsterdam, the Netherlands, 05/10/2022, Last updated: 28/11/2022 -
List item
News: EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders (updated)
CHMP, Last updated: 13/01/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 7-10 November 2022
CHMP, Last updated: 11/11/2022 -
List item
News: New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome
CMDh, Last updated: 11/11/2022 -
List item
News: EMA recommends approval of VidPrevtyn Beta as a COVID 19 booster vaccine
CHMP, Last updated: 11/11/2022 -
List item
News: EMA recommends approval of Comirnaty and Spikevax COVID-19 vaccines for children from 6 months of age
CHMP, Last updated: 19/10/2022 -
List item
News: EMA recommends approval of second adapted Spikevax vaccine
CHMP, Last updated: 19/10/2022 -
List item
Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 19 October 2022
Online, 19/10/2022, Last updated: 18/10/2022 -
List item
News: New vaccine to protect people in the EU and worldwide against dengue
CHMP, Last updated: 14/10/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 10-13 October 2022
CHMP, Last updated: 14/10/2022 -
List item
News: First therapy to treat transplant patients with post-transplant lymphoproliferative disease
CHMP, Last updated: 14/10/2022 -
List item
News: Biosimilar medicines can be interchanged
CHMP, Last updated: 19/09/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022
CHMP, Last updated: 19/09/2022 -
List item
News: New medicine to protect babies and infants from respiratory syncytial virus (RSV) infection
CHMP, Last updated: 16/09/2022 -
List item
News: EMA recommends standard marketing authorisations for Comirnaty and Spikevax COVID-19 vaccines
CHMP, Last updated: 16/09/2022 -
List item
News: Adapted vaccine targeting BA.4 and BA.5 Omicron variants and original SARS-CoV-2 recommended for approval
CHMP, Last updated: 12/09/2022 -
List item
News: New measures to minimise risk of meningioma with medicines containing nomegestrol or chlormadinone
CHMP, Last updated: 02/09/2022 -
List item
News: First adapted COVID-19 booster vaccines recommended for approval in the EU
CHMP, Last updated: 01/09/2022 -
List item
Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 1 September 2022
Online, 01/09/2022, Last updated: 23/08/2022 -
List item
News: EMA starts review of conditional marketing authorisation application for Skycovion COVID-19 vaccine
CHMP, Last updated: 18/08/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 July 2022
CHMP, Last updated: 22/07/2022 -
List item
News: EMA recommends restricting use of cancer medicine Rubraca
CHMP, Last updated: 22/07/2022 -
List item
News: EMA recommends approval of Imvanex for the prevention of monkeypox disease
CHMP, Last updated: 22/07/2022